Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38239092)

  • 1. Recurrence-risk stratification using the Beppu score and selection of perioperative chemotherapy for colorectal liver metastases.
    Beppu T; Yamamura K; Imai K; Hayashi H; Miyamoto Y
    J Surg Oncol; 2024 Apr; 129(5):893-900. PubMed ID: 38239092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-risk Patients With Colorectal Liver Metastases Assessed by the Beppu Score Can Have Excellent Survival Through Multidisciplinary Treatment Including Local Ablation.
    Beppu T; Yamamura K; Masuda T; Miyamoto H; Nasu J; Saito S; Doi K; Katsumori T; Oda T; Isiko T
    Anticancer Res; 2024 Apr; 44(4):1533-1539. PubMed ID: 38537970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation study of the JSHBPS nomogram for patients with colorectal liver metastases who underwent hepatic resection in the recent era - a nationwide survey in Japan.
    Beppu T; Yamamura K; Sakamoto K; Honda G; Kobayashi S; Endo I; Hasegawa K; Kotake K; Itabashi M; Hashiguchi Y; Kotera Y; Yamaguchi T; Natsume S; Tabuchi K; Kobayashi H; Yamaguchi K; Morita S; Kikuchi K; Miyazaki M; Sugihara K; Yamamoto M; Takahashi K;
    J Hepatobiliary Pancreat Sci; 2023 May; 30(5):591-601. PubMed ID: 36285571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indication for neoadjuvant chemotherapy in patients with colorectal liver metastases based on a nomogram that predicts disease-free survival.
    Okuno M; Hatano E; Seo S; Taura K; Yasuchika K; Nakajima A; Yazawa T; Furuyama H; Kawamoto H; Yagi S; Nishitai R; Fujikawa T; Arimoto A; Zaima M; Yoshimura T; Terajima H; Kaihara S; Manaka D; Tanaka A; Uemoto S
    J Hepatobiliary Pancreat Sci; 2014 Dec; 21(12):881-8. PubMed ID: 25155418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
    Beppu T; Sakamoto Y; Hasegawa K; Honda G; Tanaka K; Kotera Y; Nitta H; Yoshidome H; Hatano E; Ueno M; Takamura H; Baba H; Kosuge T; Kokudo N; Takahashi K; Endo I; Wakabayashi G; Miyazaki M; Uemoto S; Ohta T; Kikuchi K; Yamaue H; Yamamoto M; Takada T
    J Hepatobiliary Pancreat Sci; 2012 Jan; 19(1):72-84. PubMed ID: 22020927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.
    Goéré D; Benhaim L; Bonnet S; Malka D; Faron M; Elias D; Lefèvre JH; Deschamps F; Dromain C; Boige V; Dumont F; De Baere T; Ducreux M
    Ann Surg; 2013 Jan; 257(1):114-20. PubMed ID: 23235397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of adjuvant therapy after resection of colorectal cancer liver metastases.
    Power DG; Kemeny NE
    J Clin Oncol; 2010 May; 28(13):2300-9. PubMed ID: 20368552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases.
    Brandi G; Derenzini E; Falcone A; Masi G; Loupakis F; Pietrabissa A; Pinna AD; Ercolani G; Pantaleo MA; Di Girolamo S; Grazi GL; de Rosa F; Biasco G
    Clin Colorectal Cancer; 2013 Sep; 12(3):188-94. PubMed ID: 23773458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resectable colorectal liver metastases: optimal sequencing of chemotherapy.
    Chua TC; Morris DL
    J Gastrointest Cancer; 2012 Sep; 43(3):496-8. PubMed ID: 21365476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.
    Nordlinger B; Sorbye H; Glimelius B; Poston GJ; Schlag PM; Rougier P; Bechstein WO; Primrose JN; Walpole ET; Finch-Jones M; Jaeck D; Mirza D; Parks RW; Mauer M; Tanis E; Van Cutsem E; Scheithauer W; Gruenberger T; ; ; ; ;
    Lancet Oncol; 2013 Nov; 14(12):1208-15. PubMed ID: 24120480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative second-line chemotherapy is beneficial for resectable liver metastases that occur during or early after adjuvant chemotherapy for colorectal cancer.
    Xu D; Zhu HB; Wang YY; Jin KM; Yan XL; Li J; Wang K; Xing BC
    Int J Colorectal Dis; 2022 Apr; 37(4):805-814. PubMed ID: 35188594
    [TBL] [Abstract][Full Text] [Related]  

    Patyutko YI; Kotelnikov AG; Mamontov KG; Podluzhny DV; Ponomarenko AA
    Vopr Onkol; 2015; 61(3):439-47. PubMed ID: 26242159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a survival benefit to neoadjuvant versus adjuvant chemotherapy, combined with surgery for resectable colorectal liver metastases?
    Lubezky N; Geva R; Shmueli E; Nakache R; Klausner JM; Figer A; Ben-Haim M
    World J Surg; 2009 May; 33(5):1028-34. PubMed ID: 19234865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control arm for surgery alone is needed but difficult to obtain in randomized trials for adjuvant chemotherapy after liver resection for colorectal metastases.
    Kokudo N; Hasegawa K; Makuuchi M
    J Clin Oncol; 2007 Apr; 25(10):1299-300; author reply 1300. PubMed ID: 17401028
    [No Abstract]   [Full Text] [Related]  

  • 15. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial.
    Portier G; Elias D; Bouche O; Rougier P; Bosset JF; Saric J; Belghiti J; Piedbois P; Guimbaud R; Nordlinger B; Bugat R; Lazorthes F; Bedenne L
    J Clin Oncol; 2006 Nov; 24(31):4976-82. PubMed ID: 17075115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy.
    Kornprat P; Jarnagin WR; Gonen M; DeMatteo RP; Fong Y; Blumgart LH; D'Angelica M
    Ann Surg Oncol; 2007 Mar; 14(3):1151-60. PubMed ID: 17195913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
    Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D
    BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of preoperative chemotherapy on the intraoperative and postoperative course of liver resection for colorectal cancer metastases.
    Spelt L; Hermansson L; Tingstedt B; Andersson R
    World J Surg; 2012 Jan; 36(1):157-63. PubMed ID: 22086255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laparoscopic versus open two-stage hepatectomy for bilobar colorectal liver metastases: A bi-institutional, propensity score-matched study.
    Okumura S; Goumard C; Gayet B; Fuks D; Scatton O
    Surgery; 2019 Dec; 166(6):959-966. PubMed ID: 31395397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment strategy for patients with multiple liver metastases of colorectal origin in the era of adjuvant chemotherapy].
    Seyama Y; Matsuda M; Nishikawa T; Tani K; Inada K; Nasu K; Wada I; Maeshiro T; Miyamoto S; Umekita N
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1659-61. PubMed ID: 24393880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.